| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1097-0215(19970317)70:6<706::AID-IJC13>3.0.CO;2-7 |
| P698 | PubMed publication ID | 9096653 |
| P2093 | author name string | S K Nair | |
| D Snyder | |||
| B T Rouse | |||
| E Gilboa | |||
| P2860 | cites work | Introduction of soluble protein into the class I pathway of antigen processing and presentation | Q46305448 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 706-715 | |
| P577 | publication date | 1997-03-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts | |
| P478 | volume | 70 |
| Q77394242 | A long-lasting interferon-gamma response is induced to a single inoculation of antigen-pulsed dendritic cells |
| Q64379122 | Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity |
| Q36622359 | Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens |
| Q40389502 | An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats |
| Q35038974 | Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model |
| Q77627717 | Antigen-presenting cells in rheumatoid arthritis |
| Q53538542 | Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies. |
| Q40900120 | Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma |
| Q36380683 | Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors |
| Q73395758 | Cellular but not humoral immune responses generated by vaccination with dendritic cells protect mice against leukaemia |
| Q35602700 | CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells |
| Q77468257 | Dendritic cell responsiveness to stimulation with influenza vaccine is unimpaired in old age |
| Q47915872 | Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells |
| Q36085614 | Dendritic cells as therapeutic vaccines against cancer |
| Q73311326 | Dendritic cells transfected with interleukin‐12 and pulsed with tumor extract inhibit growth of murine prostatic carcinoma in vivo |
| Q74336550 | Differentiation of antigen-presenting cells (dendritic cells and macrophages) for therapeutic application in patients with lymphoma |
| Q73922532 | Expression of MHC and adhesion/costimulation molecules of dendritic cells from human blood during their differentiation in vitro |
| Q78028306 | Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro |
| Q33986125 | Feeding dendritic cells with tumor antigens: self-service buffet or à la carte? |
| Q45862575 | Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro. |
| Q41687574 | Human tumor antigens recognized by T-cells |
| Q36870592 | Identification of T-cell epitopes for cancer immunotherapy |
| Q40806767 | Immunization with dendritic cells pulsed with tumor extract increases survival of mice bearing intracranial gliomas |
| Q35021643 | Immunotherapy of urologic tumors: principles and progress |
| Q48478595 | Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma |
| Q73174279 | In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates |
| Q40616709 | In vitro induction of carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes by dendritic cells transduced with recombinant adenoviruses |
| Q41049213 | Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. |
| Q37352655 | Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer |
| Q28569690 | Interleukin-12 secreted by mature dendritic cells mediates activation of NK cell function |
| Q42798836 | Intratumoral administration of immature dendritic cells following the adenovirus vector encoding CD40 ligand elicits significant regression of established myeloma |
| Q45862841 | Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of established murine transplantable colon adenocarcinomas |
| Q61762182 | Les cellules dendritiques: un système cellulaire complexe |
| Q37155271 | Non-Steroidal Anti-Inflammatory Drugs, Variation in Inflammatory Genes, and Aggressive Prostate Cancer |
| Q35219642 | Notch regulates cytolytic effector function in CD8+ T cells. |
| Q37384753 | Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity |
| Q40559621 | Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine |
| Q34328457 | Progress on new vaccine strategies for the immunotherapy and prevention of cancer |
| Q41844970 | Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells |
| Q39013095 | Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells |
| Q53109846 | Trial watch: Dendritic cell-based anticancer immunotherapy. |
| Q27024047 | Trial watch: Dendritic cell-based anticancer therapy |
| Q36388529 | Trial watch: Dendritic cell-based interventions for cancer therapy |
| Q42867339 | Trial watch: Dendritic cell-based interventions for cancer therapy |
| Q40415241 | Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma |
| Q57000002 | Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity |
| Q58862665 | Tumour necrosis factor-alpha (TNF-alpha) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-alpha |
| Q40652525 | Vaccination of fusion cells of rat dendritic and carcinoma cells prevents tumor growth in vivo |
| Q73182177 | [Adoptive immunotherapy: evaluation and perspectives in the treatment of certain cancers] |
Search more.